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Abstract
Introduction:  Optimum  treatment  for  postoperative  pain  has  been  of  fundamental  importance
in surgical  patient  care.  Among  the  analgesic  techniques  aimed  at  this  group  of  patients,  tho-
racic paravertebral  block  combined  with  general  anesthesia  stands  out  for  the  good  results  and
favorable risk--beneﬁt  ratio.  Many  local  anesthetics  and  other  adjuvant  drugs  are  being  investi-
gated for  use  in  this  technique,  in  order  to  improve  the  quality  of  analgesia  and  reduce  adverse
effects.
Objective:  Evaluate  the  effectiveness  and  safety  of  paravertebral  block  compared  to  other
analgesic  and  anesthetic  regimens  in  women  undergoing  breast  cancer  surgeries.
Methods:  Integrative  literature  review  from  1966  to  2012,  using  speciﬁc  terms  in  computerized
databases  of  articles  investigating  the  clinical  characteristics,  adverse  effects,  and  beneﬁcial
effects of  thoracic  paravertebral  block.
Results:  On  the  selected  date,  16  randomized  studies  that  met  the  selection  criteria  established
for this  literature  review  were  identiﬁed.  Thoracic  paravertebral  block  showed  a  signiﬁcant
reduction of  postoperative  pain,  as  well  as  decreased  pain  during  arm  movement  after  surgery.
Conclusion:  Thoracic  paravertebral  block  reduced  postoperative  analgesic  requirement  com-
pared to  placebo  group,  markedly  within  the  ﬁrst  24  h.  The  use  of  this  technique  could  ensure
postoperative  analgesia  of  clinical  relevance.  Further  studies  with  larger  populations  are  nec-
essary, as  paravertebral  block  seems  to  be  promising  for  preemptive  analgesia  in  breast  cancer
surgery.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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PALAVRAS-CHAVE
Bloqueio
paravertebral;
Câncer  de  mama;
Complicac¸ões
pós-operatórias
Aplicac¸ão  clínica  do  bloqueio  anestésico  paravertebral  torácico  em  operac¸ões  de
mama
Resumo
Introduc¸ão:  O  adequado  tratamento  da  dor  pós-operatória  tem  sido  de  fundamental  importân-
cia nos  cuidados  com  o  paciente  cirúrgico.  Entre  as  técnicas  de  analgesia  direcionadas  para
esse grupo  de  pacientes,  o  bloqueio  paravertebral  torácico  combinado  com  a  anestesia  geral
se destaca  pelos  bons  resultados  e  pela  favorável  relac¸ão  risco-benefício.  Muitos  anestésicos
locais e  outros  fármacos  adjuvantes  vêm  sendo  investigados  para  uso  nessa  técnica,  com  vistas
a melhorar  a  qualidade  da  analgesia  e  reduzir  os  efeitos  adversos.
Objetivo:  Avaliar  a  eﬁcácia  e  a  seguranc¸a do  bloqueio  paravertebral  em  comparac¸ão  com  outros
regimes analgésicos  e  anestésicos  em  mulheres  submetidas  a  cirurgias  para  câncer  de  mama.
Métodos:  Revisão  integrativa  da  literatura  de  1966  a  2012,  feita  por  meio  de  termos  especíﬁcos
nos bancos  de  dados  informatizados,  de  artigos  que  investigaram  as  características  clínicas  e
os efeitos  adversos  e  benéﬁcos  do  bloqueio  paravertebral  torácico.
Resultados:  No  período  selecionado,  foram  identiﬁcados  16  estudos  randomizados  que
preenchiam  os  critérios  de  selec¸ão  estabelecidos  para  essa  revisão  bibliográﬁca.  O  bloqueio
paravertebral  torácico  demonstrou  uma  reduc¸ão  signiﬁcativa  da  dor  pós-operatória,  bem  como
diminuic¸ão da  dor  durante  movimentos  do  brac¸o  após  a  cirurgia.
Conclusão:  O  bloqueio  paravertebral  torácico  reduziu  a  necessidade  pós-operatória  de  anal-
gésicos quando  comparado  ao  grupo  placebo,  notadamente  dentro  das  primeiras  24  horas.  O
emprego dessa  técnica  poderia  garantir  uma  analgesia  pós-cirúrgica  de  relevância  clínica.  Novos
estudos, com  maiores  grupos  populacionais,  fazem-se  necessários,  uma  vez  que  o  bloqueio
paravertebral  parece  promissor  em  analgesia  preemptiva  para  cirurgia  de  câncer  de  mama.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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n  recent  years,  the  number  of  new  cases  of  breast  cancer
as  increased,  with  an  estimated  risk  of  52  cases  per  100
housand  women.1 Similar  to  that  seen  in  the  world  popula-
ion,  breast  cancer  became  the  leading  cause  of  mortality
mong  women.2,3 About  40%  of  the  patients  experience  clin-
cally  signiﬁcant  acute  postoperative  pain  (>5  on  the  Visual
nalog  Scale).  This  indicates  that,  as  in  other  surgical  pro-
edures,  pain  treatment  is  not  sufﬁcient.  Moreover,  acute
ostoperative  pain  is  a  major  risk  factor  for  chronic  pain
evelopment  in  women  following  breast  surgery.4 There-
ore,  a  therapeutic  approach  to  pain  after  breast  cancer
urgery  is  necessary.
Pain  control  after  breast  surgery  procedures  is  critical.  In
ddition,  there  is  the  need  for  treatment  of  postoperative
omorbidities,  as  well  as  nausea  and  vomiting,  considered
s  the  three  main  variables  related  to  restriction  of  hos-
ital  discharge  in  patients  undergoing  surgical  procedures,
uch  as  quadrantectomy  and  mastectomy.  Nausea  and  vom-
ting  are  relatively  under  control  with  the  advent  of  new
ntiemetic  agents.  Paravertebral  blockade  has  been  shown
o  be  a  viable  option  to  the  classical  multimodal  analge-
ia,  particularly  in  recent  years  with  the  use  of  opioids  and
nti-inﬂammatory  drugs.5With  the  advent  of  ultrasound  to  guide  anesthetic  blocks,
ts  use  has  become  a  preoperative  assessment  tool  that  pre-
icts  the  possibility  of  performing  a  neuraxial  blockade.6
he  use  of  this  ancillary  study  can  help  prevent  injury  to
E
s
itructures  such  as  vessels  and  pleura,  as  well  as  allowing
ccurate  injection  of  local  anesthetic  under  direct  visualiza-
ion.  A  previous  study  reported  that  thoracic  paravertebral
lock  (TPVB)  may  be  considered  an  efﬁcient  option  that  pro-
ides  anesthesia  and  postoperative  (PO)  analgesia  for  breast
urgery,  as  well  as  a  reduction  in  pain  intensity  and  nausea
nd  vomiting  drug  consumption.7
Despite  the  growing  number  of  articles  assessing  the  post-
perative  management  of  acute  and  chronic  pain,  we  found
o  integrative  review  assessing  the  topic  in  question.  Thus,
he  aim  of  this  study  was  to  assess  the  efﬁcacy  and  safety  of
PVB,  compared  with  other  analgesics  and  anesthetic  reg-
mens,  to  control  post-surgical  pain  in  women  undergoing
reast  cancer  surgery.
ethods
ntegrative  literature  review  of  randomized  and/or
ouble-blind  studies,  with  population  and  hospital
pproaches.  The  search  was  conducted  in  the  follow-
ng  computerized  databases  during  February  2013:  PubMed
http://www.pubmed.gov),  Cochrane  Controlled  Trials
egister  (Central,  The  Cochrane  Library  --  http://www.
hecochranelibrary.com.br),  Embase  (http://www.embase.
om),  and  Lilacs  (http://lilacs.bvsalud.org).The  limits  used  for  literature  search  were:
nglish  or  Spanish  publications,  female  human,
urveyed  from  1966  to  2012.  The  terms  used  to
dentify  the  studies  were:  breast  surgery  [MeSH],
Paravertebral  anesthetic  block  and  breast  surgery  
82 articles identified in
databases
50 potentially relevant
studies
15 articles were unreadable,
according to predefined criteria
(non-randomized trials, 3 studies
in Russian language).
20 studies excluded due to
irrelevance to the specific topic
15 articles with useful information
included in the integrative review
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DFigure  1  Systematization  of  the  study  selection  process.
postoperative  analgesia  [MeSH],  postoperative  chronic
pain  [MeSH],  paravertebral  block  [MeSH],  and  preincisional
paravertebral  block  [MeSH].  The  articles  that  answer  the
established  guiding  question  and  met  the  following  inclusion
criteria  were  adopted:  studies  assessing  effects,  clinical
characteristics,  efﬁcacy,  and  safety  of  paravertebral  block
associated  with  general  anesthesia  (GA)  and  placebo-
controlled  in  women  undergoing  breast  cancer  surgery;
randomized  trials  indexed  in  the  above  mentioned  database
from  1966  to  2012,  whose  abstracts  were  available  online.
Exclusion  criteria  were  non-randomized  publications,
editorials,  reviews,  and  case  reports.
The  selected  articles  (Fig.  1)  were  read  in  full  and
analyzed  based  on  a  checklist  considering  the  following
characteristics:  study  type  and  design,  year  and  place;
assessment  methods;  number  of  participants  (inclusion  cri-
teria,  age  group,  type  of  surgery,  anesthetic  technique,
study  objectives,  control  algorithm  for  pain  management,
use  of  ﬁxed  drug  for  postoperative  pain  in  both  study  groups
--  TPVB  and  GA  or  placebo,  prophylaxis  against  postoperative
vomiting);  major  clinical  outcomes.
Results
In  total,  82  studies  were  identiﬁed  of  which  15  met  the  inclu-
sion  criteria  (Fig.  1).  Selected  articles  were  inserted  in  a
table  (Table  1)  to  be  compared.  Besides  these,  other  docu-
ments  have  been  cited  throughout  this  review  for  theoretical
basis  and  topic  discussion.  Studies  that  clearly  did  not  meet
the  inclusion  criteria  were  excluded  and  copies  of  texts  that
were  potentially  relevant  were  obtained.
Of  the  15  studies  included,  825  participants  undergo-
ing  breast  surgery  were  randomly  assigned  to  intervention
or  control  groups.  Types  of  surgery  were:  tumor  removal,
mastectomy  with  or  without  axillary  dissection,  quad-
rantectomy,  and  mastectomy  followed  by  immediate
reconstruction.  Only  one  investigator  reported  detailed  sur-
gical  statistics  and  data  operation.7 The  main  inclusion
criteria  for  the  research  were:  adults  (over  18  years  of  age)
and  ASA  physical  status  class  I--III,  according  to  the  American
Society  of  Anesthesiologists  (ASA).  Coagulation  disorders,
treatment  with  anticoagulants,  allergy  to  local  anesthesia,
and  infection  at  the  site  of  injection  were  the  exclusion
criteria  in  all  studies.
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The  technique  described  by  Eason  and  Wyatt  was  used
o  establish  TPVB.8 Local  anesthetic  was  injected  into  the
aravertebral  space  between  the  third  and  fourth  thoracic
evels.  The  most  commonly  administered  local  anesthetic
as  0.25--0.5%  bupivacaine7,9--12;  2%  lidocaine  was  used  in
ne  study,13 while  another  tested  a mixture  of  2%  lido-
aine,  0.5%  bupivacaine  with  epinephrine,  fentanyl,  and
lonidine.14 The  addition  of  fentanyl  (0.05%)  was  associated
ith  nausea  and  vomiting,  while  clonidine  resulted  in  hemo-
ynamic  changes  (arterial  hypotension).14 Levobupivacaine
0.1%)  administered  alone  was  not  effective  in  the  TPVB
nalgesia  after  breast  surgery.  Ropivacaine  (0.5%)  acted
aster  and  offered  increased  anesthesia  time.15--17 In  most
tudies,  the  main  agents  used  for  induction  of  anesthesia
ere  propofol,  fentanyl  or  sufentanil.  Thiopental  was  used
n  one  study.13 Analgesia  was  provided  by  bolus  adminis-
ration  of  various  opioids.  Different  additional  analgesics
acetaminophen,  traditional  nonsteroidal  anti-inﬂammatory
rugs  [NSAIDs],  coxibs)  were  distributed  in  all  works.  In
rder  to  reduce  the  prevalence  of  PO  nausea  and  vomit-
ng,  dexamethasone,  ondansetron  or  both  were  used  before
he  operation,  according  to  the  protocol  of  each  institution.
atients  were  ventilated  with  carbon  dioxide  absorption
nesthetic  system  and  positive  pressure  mechanical  venti-
ation.
There  was  a  signiﬁcant  difference  between  TPVB  and  GA
roups  regarding  the  scores  of  ‘‘worst  postoperative  pain’’
2  h,  2--24  h,  and  24--48  h.  Heterogeneity  inﬂuenced  the
esults  at  all  times.  Different  data  on  levels  of  pain  at  rest
ere  selected  in  two  studies9,10 and  there  was  only  a  slightly
etter  pain  score  during  all  times  evaluated  in  TPVB  group,
lthough  not  statistically  signiﬁcant.  There  was  signiﬁcant
eduction  in  levels  of  pain  at  rest  in  the  period  of  2--24  h
nd  at  all  times  during  movement.  Five  studies,10--14 which
ncluded  data  from  215  patients,  compared  levels  of  acute
ostoperative  (VAS/NRS)  pain  in  women  undergoing  surgery
ith  TPVB  and  GA  compared  with  GA  alone  in  the  treat-
ent  of  acute  postoperative  pain.  There  was  a  signiﬁcant
ifference  in  the  levels  of  ‘‘worst  pain  during  the  postop-
rative  period’’  between  TPVB  and  control  groups  (<2  h).
ata  on  the  need  for  rescue  analgesia  were  assessed  in  four
urveys.11--14 Fewer  patients  required  opioids  during  0--24  h
fter  surgery  with  TPVB  and  GA  compared  with  GA  alone.
PVB  group  also  required  a  lesser  amount  of  morphine  during
he  interval  of  0--24  h.
Four  studies11--14 that  included  248  women  reported  accu-
ately  the  number  of  patients  who  suffered  adverse  effects
fter  surgery  with  TPVB  and  GA  compared  with  GA  alone.
here  were  no  reports  of  nerve  damage  or  accidental  pneu-
othorax.  It  is  noteworthy  that  TPVB  may  have  prevented
n  increase  in  pain  intensity  in  breast  region  after  radio-
herapy  in  patients  who  had  no  axillary  dissection.  Analgesic
ffect  duration  in  TPVB  and  GA  group  was  twice  as  high  when
ompared  to  control  group  (GA).
iscussionnsufﬁcient  and  ineffective  pain  control  after  surgery  for
reast  cancer  may  delay  recovery,  limit  hospital  discharge,
nd  increase  the  care  costs  of  surgery,  as  it  can  result
n  chronic  pain.  Several  studies  have  investigated  the
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Table  1  Main  characteristics  of  studies  of  paravertebral  blockade  in  breast  cancer  surgery.
Author, year,
place
Population (n) Study type Mean age Assessment
method
Study objective Anesthetics
Blockade route
Anesthetic technique
details
Complications Main results
Pusch et al.,
1999;  Austria
86
42 -- GA;
44  -- TPVB
Prospective GA: 53 years;
TPVB:  51 years
VAS Compare TPVB with
GA  in breast cancer
surgery
(quadrantectomy,
simple  mastectomy;
mastectomy and
axillary  dissection)
(1) TPVB: injection of
5%  bupivacaine
(0.3 mL kg−1) in the
T4  level (maximum
dose  of 150 mg);
(2) GA: IV induction
of  propofol
(2--3 mg kg−1) and
fentanyl (2.3 mcg);
(3) SPVB
Vomiting
GA: 12 patients;
TPVB:  4 patients
TPVB was a good
alternative  to breast
cancer  surgery, with
good  results
Klein  et al.,
2000;  North
Carolina
59
30 -- GA;
29 -- TPVB
Randomized,
prospective,
and
double-blind
GA: 44 years;
TPVB:  48 years
VAS; NRS Compare TPVB with
GA  in patients
undergoing breast
reconstruction after
breast  cancer
(1) TPVB: injection of
4  mL of 0.5%
bupivacaine with 1:
400,000  epinephrine
in  T1--T7 level;
(2)  GA: induction
with  propofol
(1.5--2 mg kg−1),
fentanyl with
isoﬂurane
(1--3  mcg kg−1), and
NO  in oxygen;
(3)  MPVB
Vomiting
30 min -- TPVB × GA
(p  = 0.11);
1 h -- TPVB × GA
(p  = 0.26);
24 h -- TPVB × GA
(p  = 0.04)
TPVB was a surgical
alternative  to breast
reconstruction,
offering  less pain and
nausea  compared to
GA  alone
Terheggen
et  al., 2002;
Arnhem/
Netherlands
25
10 -- TPVB;
15  -- GA
Randomized and
prospective
TPVB: 48 years;
GA:  51 years
VAS Evaluate the
effectiveness of TPVB
with  GA in patients
undergoing
quadrantectomy with
or  without sentinel
lymph  node
(1) TPVB: injection of
5%  bupivacaine
(15--20 mL) with 1:
200,000 epinephrine,
through a catheter
inserted  at T3--T4
interspace.  Catheter
was  removed after
surgery;
(2)  GA: induction
with  fentanyl
(1--1.5 mcg kg−1) and
propofol infusion
(3--5  mcg mL−1); with
mixture  of oxygen
and  NO (1:2);
(3)  SPVB
(1) Dyspnea and
hypotension (1 TPVB
patient);
(2)  Accidental pleural
puncture  (1 TPVB
patient);
(3)  There was no
complication in GA
group
TPVB risk--beneﬁt
showed no favorable
results  for this type
of  surgery
Kairaluoma
et  al., 2004;
Finland
60
30 -- TPVB;
30 -- GA
Randomized TPVB: 52 years;
GA:  55 years
VAS; Motion
evaluation
(ﬂexion and
abduction)
Assess the possible
effects  of TPVB with
bupivacaine  or saline
before  GA
(1) TPVB: bupivacaine
5  mg mL−1 in T3 level
and  lidocaine 2--5 mL;
(2)  GA: induction
with  propofol
(2--3 mg kg−1).
Sevoﬂurane and 40%
oxygen  (BIS
monitoring). All
patients  were
intubated and
ventilated with PPVC;
(3)  SPVB
Vomiting
GA: 17 patients;
TPVB:  10 patients;
p  = 0.069
‘There was signiﬁcant
difference  between
groups.  TPVB allowed
greater  movement of
the  shoulder; less
pain  (p = 0.019).
There was rapid
recovery  of
psychomotor
function, as well as
ocular control in
TPVB  group
Iohom  et al.,
2006;  Ireland
29
15 -- GA;
10  -- TPVB
Randomized and
prospective
GA: 59 years;
TPVB:  65 years
VAS McGill Pain
Questionnaire
Compare the effects
of  two analgesic
regimens and the
probability  of chronic
pain  development
after breast surgery;
Associate  plasma
concentrations of NO
and  the likelihood of
subsequent
development of
chronic  pain
(1) TPVB: 1%
lidocaine (2--5 mL) at
T3  level;
(2)  GA: induction
with  8% sevoﬂurane
in  100% oxygen;
(3)  CPVB
One patient in group
CPVB  developed
Horner’s syndrome
There was no
association  between
NO  and the
subsequent
development of
chronic  pain after
axillary  dissection
Kairaluoma
et  al., 2006;
Finland
60
30 -- TPVB;
30  -- GA
Randomized,
prospective,
and
double-blind
-- VAS; POMS; NRS Determine if  TPVB
would  be associated
with  less neuropathic
pain  after surgery for
breast  cancer
(axillary dissection
and  sentinel node)
(1) TPVB: 0.5%
bupivacaine
(1.5  mg kg−1) at T3
level;
(2)  GA: induction
with  propofol
(2--3 mg kg−1).
Sevoﬂurane and 40%
oxygen  (BIS
monitoring). All
patients  were
intubated and
ventilated with PPVC;
There were no
reports  of
postoperative
complications
Incidence of stiffness
in  surgical scar,
sensory  disorders,
musculoskeletal
symptoms,  restriction
of  shoulder
movement, and
edema  were not
signiﬁcantly  different
between  groups. No
patient  reported
phantom pain(3)  SPVB
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Table  1  (Continued  )
Author, year,
place
Population (n) Study type Mean age Assessment
method
Study objective Anesthetics
Blockade route
Anesthetic technique
details
Complications Main results
Burlacu et al.,
2006;  Ireland
52
(1) 13--19 mL of
levobupiva-
caine -- TPVB;
(2)  19 mL of
levobupiva-
caine and
0.25% fentanyl
--  TPVB;
(3) 19 mL of
levobupiva-
caine and
0.25% clonidine
-- TPVB;
(4)  Control
group -- GA
Group 1: 51
years;
Group  2: 54
years;
Group  3: 53
years;
Group  4: 57
years
Randomized VAS; OAA/S Compare the
different
postoperative effects
between  GA and
TPVB
(1) Group 1: 19 mL
bolus
levobupivacaine
0.25% plus 1 mL saline
followed  by an
infusion  of
levobupivacaine
0.1%;
(2)  Group 2: 19 mL
bolus
levobupivacaine
0.25% plus fentanyl
50  mg mg (1 mL de
volume) followed by
infusion  of
levobupivacaine
0.05%  with fentanyl
1  g mL−1
(3) Group 3: 19 mL
bolus
levobupivacaine
0.25% plus clonidine
150  mg (1 mL volume)
before surgical
incision, followed by
an  infusion of
levobupivacaine
0.05%  with clonidine
(3  mg mL−1) at T3
level;
(4)  GA: induction
with  propofol
(2--3 mg kg−1);
(5) CPVB
Nausea
(p = 0.04)
TPVB signiﬁcantly
decreased
postoperative pain
(quadrantectomy,
mastectomy,  and
mastectomy  followed
by  immediate
reconstruction)
Moller  et al.,
2007;
Denmark
79
38 -- TPVB;
41  -- GA
TPVB: 57.6
years;
Placebo: 57.2
years
Randomized,
double-blind
NRS; PONV Examine whether
TPVB  along with
propofol  and
laryngeal mask
performed before GA
improves
postoperative
analgesia  in
mastectomy with SNB
or  tumor resection
(1) TPVB: 0.5%
ropivacaine (30 mL);
lidocaine (5 mL) in
transverse process at
C7--T5  level;
(2)  GA: propofol
(2--3  mg kg−1) and
fentanil;
(3)  MPVB
(1) Nausea -- TPVB
and  GA (7)/placebo
(9);
(2)  Vomiting -- TPVB
and  GA (2)/placebo
(1);
(3)  Sleep disorders --
TPVB  and GA
(8)/placebo (7)
Fentanyl consumption
was  signiﬁcantly
lower  in TPVB group
during  anesthesia.
Pain  severity was
lower  in TPVB group
with  p < 0.0001
Dabbagh,  Elyasi;
2007;  Iran
60
30 -- TPVB;
30  -- GA
-- Randomized NRS Compare whether
TPVB  intervenes
positively in pain
scores,  morphine
consumption as
rescue  analgesia, and
length  of hospital
stay  after simple
mastectomy
(1) TPVB: injection of
2%  lidocaine (15 mL)
at  T4 level;
(2)  GA: thiopental
with  halothane
(4--5 mg kg−1) in a
mixture of 1:1 NO
and  oxygen;
(3) SPVB
There were no
reports  of
postoperative
complications
TPVB produced fewer
complications,
decreased  pain
intensity,  can be an
alternative  method
for  breast surgery
Sidiripoulou
et  al., 2007;
Italy
48
24 -- TPVB;
24  -- GA
TPVB: 64 years;
GA:  67 years
Randomized VAS; Motion
evaluation
(shoulder
abduction and
exter-
nal/internal
rotation)
Compare GA and
TPVB  regarding
analgesic efﬁcacy
and  morphine
consumption after
mastectomy
(1) TPVB: 2%
lidocaine  (5 mL) at
T1--T5 levels;
(2)  GA: induction of
propofol  and
sufentanil
(0.3--0.5 mcg kg−1);
(3)  SPVB
Nausea and vomiting
(1)  TPVB and GA: 5
patients;
(2)  Placebo: 15
patients
Vomiting was more
frequent  in GA group.
Morphine
consumption  did not
differ  between the
two  groups.
Incidence of nausea
and  vomiting was
lower  in TPVB group
McElwain  et al.,
2008;  Ireland
37
(1) 15 min: 19;
(2) 30 min: 18
(1) 15 min: 55
years;
(2) 30 min: 54
years
Prospective,
randomized,
double-blind
VAS Compare pain scores
between  TPVB and
GA
(1) 15 min --
levobupivacaine --
0.2%  (bolus: 3 mL);
(2) 30 min --
levobupivacaine --
0.2%  (bolus: 8 mL);
(3) GA: induction of
0.25%
levobupivacaine
20  mL bolus
(paracetamol 1 g;
diclofenac 75 mg;,
ondansetron 4m;,
morphine
0.15  mg kg−1)
Horner’s syndrome,
asymptomatic
bradycardia,
infection, catheter
disconnection
There were no
signiﬁcant
differences in pain
intensity  and arm
movements.  There
were  fewer side
effects  and greater
patient  satisfaction
with  TPVB
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Table  1  (Continued  )
Author, year,
place
Population (n) Study type Mean age Assessment
method
Study objective Anesthetics
Blockade route
Anesthetic technique
details
Complications Main results
Boughey et al.,
2009;  United
States
80
41 -- GA;
39  -- TPVB with
GA
GA:  57.9 years;
TPVB:  53 years
Prospective and
randomized
NRS Evaluate the effect
of  GA using TPVB.
The  objective is pain
control  after
mastectomy without
plastic  reconstruction
(1) TPVB: 1% and 5%
ropivacaine  with
1:400,000
epinephrine at T1--T6
level;
(2)  GA: monitored
cardiovascular
parameters;
3--6  mL of 5%
ropivacaine with
1:4,000,000
epinephrine;
prophylaxis for
nausea  and vomiting
(dexamethasone,
ondansetron, and
promethazine)
(3)  MPVB
There was no
difference between
groups  in scores for
nausea  and vomiting
and  other
complications
TPVB signiﬁcantly
decreased
postoperative pain
Buckenmaier
et  al., 2010;
Pennsylvania
73
(1) 23 --
Placebo;
(2)  27 --
CPVB  + GA;
(3) 26 --
CPVB  + GA
(1) Placebo:
58.4 years;
(2)  54.3 years;
(3)  54.8 years
Prospective,
randomized,
double-blind,
and placebo-
controlled
Likert scale;
Wong-Baker
Faces  Pain
Rating Scale;
McGill  Pain
Questionnaire;
Proﬁle of Mood
States; Mc
Cockle  Symptom
Distress Scale
Compare pain,
nausea, and mood
between TPVB and
GA  groups
(1) TPVB: 5 mL
ropivacaine and
1:400,000
epinephrine at T1--T6
level;
(2)  GA: lidocaine 1%
com  epinefrina
1:200,000
(3)  CBPV
Seroma (2);
Lymphedema (2);
Surgical  site infection
(1);
Horner’s syndrome
(1)
TPVB use was not
sustained  with
signiﬁcance  in this
study
Ibarra  et al.,
2011;  Spain
29
14 -- GA
15  -- GA +TPVB
-- Randomized VAS; Neurostim-
ulation for
TPVB;
telephone
Interview
Determine the
association between
anesthetic technique,
intensity  of
postoperative pain,
and  chronic pain
development
(1) Balanced
anesthesia with
sevoﬂurane,
remifentanil;
(2)  Balanced
anesthesia with
sevoﬂurane,
remifentanil
combined with TPVB
Group 1:
(1)  Neuropathic pain:
43%;
(2)  Phantom breast:
21%;
(3)  Myofascial pain:
33%;
SDPM:  50%
Group 2:
Neuropathic pain:
6.7%;
Phantom  breast: 0%;
Myofascial  pain: 43%;
SDPM:  6.7%
Neuropathic pain was
more  frequent in GA
patients,  with a
greater  tendency to
develop  phantom
breast sensation
Bhuvaneswari
et  al., 2012;
India
48
(G1) 12;
(G2) 12;
(G3) 12;
(G4) 12
G1: 50.7 years;
G2:  49.1 years;
G3:  48.7 years;
G4:  49 years
Randomized VRS; NRS; PONV Evaluate the
effectiveness of
lower  concentrations
of  bupivacaine with
or  without fentanyl in
PVB  in patients
undergoing breast
cancer  surgery
(G1): 0.25% bupiva-
caine  + bupivacaine
5 mg mL−1;
(G2) 0.25% bupiva-
caine  + bupivacaine
5 mg mL−1 + fentanil --
2  mg mL−1;
(G3) 0.5% bupiva-
caine  + bupivacaine
5 mg mL−1;
(G4) Saline
There were no
complications
Results show that
analgesic
consumption, pain
assessment,  and
duration  of analgesia
were  comparable
among patients
receiving TPVB with
0.5%  bupivacaine and
0.25%  bupiva-
caine + fentanyl.
0.25% bupiva-
caine + epinephrine
combined with
fentanyl  (2 g mL−1)
provides excellent
postoperative
analgesia comparable
to  0.5% bupiva-
caine  + epinephrine,
with  the advantage
of  a lower toxicity
proﬁle  when used for
a  single level of TPVB
for  breast surgery
GA, general anesthesia; BIS, bispectral index; TPVB, thoracic paravertebral blockade; CPVB, continuous catheter -- paravertebral block-
ade; VAS, Visual Analog Scale; MPVB, multiple injections -- paravertebral blockade; mcg, micrograms; NRS, numeric scale; OAA/S,
Mood
SPVB
f
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iObserver’s Assessment of Alertness and Sedation; POMS, Proﬁle of 
nausea and vomiting; PPVC, positive pressure controlled volume; 
easibility  of  TPVB  in  order  to  reduce  pain  after  breast
urgery.18 In  the  analysis  of  the  included  studies,  we
bserve  considerable  evidence  that  TPVB  followed  with  GA
rovided  better  PO  analgesia  with  little  adverse  effects
ompared  with  other  analgesic  treatment  strategies.  This
i
A
a
w States; NO, nitric oxide; PO, postoperative; PONV, postoperative
, single injection -- paravertebral blockade.
ndicates  that  perioperative  TPVB  is  a viable  method,  as
t  reduces  postoperative  pain  with  fewer  complications.
nother  important  factor  for  the  successful  completion  of
 TPVB  is  the  choice  of  appropriate  anesthetic  agents,  as
ell  as  the  technique  to  manage  them  and  proper  dosage.
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By  analyzing  the  present  review  data,  it  is  perceived  that
there  was  variation  in  the  concentration  of  drugs,  in  the
combination  with  different  adjuvants,  and  in  local  anes-
thetics  administered  into  paravertebral  space.  A  controlled
study,  which  assessed  0.5%  ropivacaine  versus  0.5%  bupiva-
caine  in  70  women  undergoing  modiﬁed  radical  mastectomy,
showed  that  the  ﬁrst  offers  a  faster,  broader  and  lasting  sen-
sory  block  than  the  second,  but  the  analgesic  efﬁcacy  of  both
local  anesthetic  was  equipotent.19
Postoperative  chronic  pain,  including  paresthesia,  inter-
costobrachial  neuralgia,  and  phantom  breast  pain  affect
25--50%  of  the  patients  after  breast  cancer  surgery.20 The
predictive  risk  factors  for  the  onset  of  persistent  neuro-
pathic  pain  after  this  type  of  surgery  are  the  adjuvant
radiotherapy  and  chemotherapy,  pain  prior  to  surgery,  type
of  surgery,  nerve  damage  --  intercostobrachial  nerve,  psy-
chosocial  factors,  anxiety,  depression,  and  young  women.20
A  moderate  decrease21 was  seen  in  the  aforementioned  stud-
ies  in  postoperative  chronic  pain  between  6  and  12  months
in  patients  who  received  GA  with  TPVB  compared  with  GA
alone.  However,  it  must  be  analyzed  with  caution  due  to  the
limited  number  of  included  trials  and  heterogeneity.  There-
fore,  there  is  need  to  develop  further  studies  to  investigate
the  possible  preventive  role  of  TPVB  in  the  incidence  of
chronic  postoperative  pain  in  patients  who  underwent  breast
surgery.
The  surgical  tissue  damage  also  results  in  spinal  sensitiza-
tion;  for  example,  metabolic  activation  and  hypersensitivity
of  the  spinal  cord  nociceptive  neurons,  expansion  of  sensory
receptive  ﬁelds,  and  changes  in  processing  innocuous  stim-
uli.  These  postoperative  neuroplastic  changes  underlie  the
development  of  ‘‘pathological’’  pain,  which  is  characterized
both  by  hyperalgesia  (primary  or  secondary)  and  allodynia.21
Thus,  an  effective  analgesia  before  the  nociceptive  stim-
ulus  could  reduce  the  risk  of  chronic  postoperative  pain
syndrome.
The  pain  experienced  during  movement  was  lower  when
COX-2  inhibitors  were  not  administered  and  none  of  these
patients  developed  mammary  pain  syndrome  after  surgery.
The  evidence  suggests  a  substantial  increase  in  the  lev-
els  of  COX-E  in  the  spinal  cord  after  peripheral  damage.22
COX-2  inhibition,  if  applied  immediately  after  surgery,  can
help  reduce  the  prostanoids  production  and  act  on  neuronal
changes  that  may  contribute  to  the  development  of  chronic
pain.12,22
Nitric  oxide  (NO)  is  related  to  both  the  development  and
maintenance  of  hyperalgesia.23 Three  optional  mechanisms
have  been  proposed  to  explain  the  nociceptor  sensitization
induced  by  NO:  (1)  NO  may  increase  the  release  of  an  algesic
substance,  such  as  prostaglandin  E2;  (2)  NO  may  inhibit  the
action  of  an  endogenous  antinociceptive  substance  that  acts
on  peripheral  nociceptors;  or  (3)  NO  may  act  directly  on
nociceptors.24,25 In  addition,  pharmacological  studies  indi-
cate  that  central  sensitization  is  at  least  partially  mediated
by  the  activation  of  N-methyl-d-aspartate  receptors,  which
could  lead,  ultimately,  to  the  production  of  NO,  although
the  link  between  the  local  and  systemic  production  is  not
deﬁned.  The  perioperative  proﬁle  of  NO  after  breast  surgery
was  similar  to  other  proﬁles  in  different  types  of  surgeries
(18),  with  a  marked  decrease  12  h  after  the  operation.12 The
fact  that  no  other  difference  between  groups  was  detected
can  be  attributed  to  the  small  number  of  patients  per  group.
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A  retrospective  analysis  of  129  patients  undergoing  mas-
ectomy  and  axillary  dissection  showed  a  low  risk  of  cancer
ecurrence  in  those  who  received  TPVB  with  GA  com-
ared  with  those  who  received  GA  alone.  Relevant  evidence
ndicates  that  the  surgical  procedure,  which  releases  can-
er  cells  directly  into  the  circulation;  volatile  anesthetics,
hich  weaken  immunity;  postoperative  use  of  opioids;  pro-
ngiogenic  factors;  and  pain  itself  are  all  associated  with
ancer  recurrence.25 Studies  have  reported  a  reduced  need
or  the  use  of  postoperative  morphine  in  patients  of  TPVB
roup,26 indicating  a  potential  pathophysiological  mecha-
ism  for  a  lower  recurrence  of  breast  cancer.  Added  to  these
actors  is  the  hypothesis  that  some  local  molecular  mecha-
ism  in  peripheral  nerves  may  be  responsible  for  increasing
he  duration  quality  of  the  local  anesthetic  block  and  pain
ontrol  after  addition  of  opioids.  However,  this  result  should
e  analyzed  with  caution,27--30 due  to  the  limited  number  of
ncluded  studies  and  signiﬁcant  heterogeneity.
The  results  of  this  review  are  limited  because  of  the
linical  heterogeneity  of  the  included  studies.  First,  pain
evels  were  calculated  both  by  Visual  Analog  Scale  (VAS)  and
umerical  rating  scale  (NRS).  Only  three  studies  explicitly
etailed  pain  during  rest  and  arm  movement  (ﬂexion,  abduc-
ion,  external  and  internal  rotations).  Second,  the  pain
cores  depend  on  the  extent  of  breast  surgery.  This  indicates
hat  less  invasive  operations,  such  as  segment  intersections,
roduced  lower  levels  of  pain  than  mastectomy  with  axillary
issection.  Third,  the  type  of  local  anesthetics  and  adju-
ants,  including  clonidine  or  opioids,  varied  among  studies,
hich  may  have  inﬂuenced  the  assessment  of  pain  severity.
owever,  there  is  evidence  that  ropivacaine,  bupivacaine,
evobupivacaine,  and  lidocaine  provide  similar  analgesia
nd  the  administration  of  adjuvants  did  not  improve  the
nalgesic  efﬁcacy.  Nevertheless,  data  are  lacking  concern-
ng  the  proper  dosage  of  local  anesthetic  used  in  TPVB  in
reast  surgery.  Fourth,  the  different  techniques  for  estab-
ishing  paravertebral  blockade  (SPVB,  MPVB,  and  TPVB  --
ingle  injection  paravertebral  blockade,  multiple  injections
aravertebral  blockade,  thoracic  paravertebral  blockade,
espectively)  may  play  an  important  role  in  the  efﬁcacy  of
nalgesia.  We  found  a  trend  toward  more  prolonged  analge-
ia  after  the  combination  of  GA  and  TPVB,  which  in  turn
enerated  a  reduced  need  for  opioid  consumption,  as  it
educed  the  algesic  sensation.
onclusion
here  is  a  number  of  evidence  on  the  beneﬁts  offered  by  the
ombination  of  TPVB  and  GA  in  adequate  control  of  postop-
rative  pain,  lower  consumption  of  opioids,  and  few  adverse
ffects  (nausea,  vomiting,  pleural  puncture,  pneumothorax)
ompared  with  other  treatment  regimens  with  analgesics.
owever,  these  results  are  limited  by  clinical  heterogene-
ty  due  to  the  application  of  different  procedures  (surgical,
nesthetic  and  analgesic  doses).  Further  studies  are  needed
o  determine  the  beneﬁts  of  the  technique.onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
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